Bioverativ Employee Directory
Biotechnology ResearchMassachusetts, United States11-50 Employees
Bioverativ is a biotechnology company focused on advancing therapies for hemophilia and other rare blood disorders through research, development, and commercialization. It is based in Waltham, Massachusetts, and operates as part of Sanofi following an acquisition completed in 2018. The company has sought to collaborate with the blood disorders community and has introduced hemophilia therapies that represented the first major advancements in the field in more than two decades. Bioverativ serves patients with hemophilia and related conditions, as well as the broader blood disorders community, by developing therapeutic options to address unmet medical needs. Within the biotechnology landscape, it is positioned in the hemophilia segment of the industry and operates under the umbrella of Sanofi, reflecting a connection to a larger global pharmaceutical group.